These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 30132514)
1. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling. Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514 [TBL] [Abstract][Full Text] [Related]
2. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK. Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Wu QX; Yuan SX; Yang JQ; Yu Y; Wu K; He BC; Sun WJ Oncol Rep; 2016 May; 35(5):2691-8. PubMed ID: 26986967 [TBL] [Abstract][Full Text] [Related]
3. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway. Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874 [TBL] [Abstract][Full Text] [Related]
4. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells. Wu QX; Yuan SX; Ren CM; Yu Y; Sun WJ; He BC; Wu K Oncol Rep; 2016 Jun; 35(6):3341-8. PubMed ID: 27108927 [TBL] [Abstract][Full Text] [Related]
5. BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells. Liu RX; Ren WY; Ma Y; Liao YP; Wang H; Zhu JH; Jiang HT; Wu K; He BC; Sun WJ Int J Oncol; 2017 Sep; 51(3):907-917. PubMed ID: 28731124 [TBL] [Abstract][Full Text] [Related]
6. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112 [TBL] [Abstract][Full Text] [Related]
7. BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer. Yuan SX; Wang DX; Wu QX; Ren CM; Li Y; Chen QZ; Zeng YH; Shao Y; Yang JQ; Bai Y; Zhang P; Yu Y; Wu K; Sun WJ; He BC Oncol Rep; 2016 Feb; 35(2):939-47. PubMed ID: 26555012 [TBL] [Abstract][Full Text] [Related]
8. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling. Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848 [TBL] [Abstract][Full Text] [Related]
9. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. Bu HQ; Luo J; Chen H; Zhang JH; Li HH; Guo HC; Wang ZH; Lin SZ Int J Oncol; 2012 Sep; 41(3):949-58. PubMed ID: 22710877 [TBL] [Abstract][Full Text] [Related]
10. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells. Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779 [TBL] [Abstract][Full Text] [Related]
12. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest. Chen Y; Miao ZH; Zhao WM; Ding J FEBS Lett; 2005 Jul; 579(17):3683-90. PubMed ID: 15963507 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells. Zeng YH; Zhou LY; Chen QZ; Li Y; Shao Y; Ren WY; Liao YP; Wang H; Zhu JH; Huang M; He F; Wang J; Wu K; He BC Oncol Rep; 2017 Jul; 38(1):456-464. PubMed ID: 28534975 [TBL] [Abstract][Full Text] [Related]
14. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells. Cordero-Herrera I; Martín MA; Bravo L; Goya L; Ramos S Nutr Cancer; 2013; 65(5):718-28. PubMed ID: 23859040 [TBL] [Abstract][Full Text] [Related]
15. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells. Park SH; Seong MA; Lee HY Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187 [TBL] [Abstract][Full Text] [Related]
16. Anti-colon cancer effect of caffeic acid p-nitro-phenethyl ester in vitro and in vivo and detection of its metabolites. Tang H; Yao X; Yao C; Zhao X; Zuo H; Li Z Sci Rep; 2017 Aug; 7(1):7599. PubMed ID: 28790461 [TBL] [Abstract][Full Text] [Related]
17. Diterpenoid C of Radix Curcumae: an inhibitor of proliferation and inducer of apoptosis in human colon adenocarcinoma cells acting via inhibiting MAPK signaling pathway. Shen Y; Lu B; Zhang S; Ma ZJ Pharm Biol; 2014 Sep; 52(9):1158-65. PubMed ID: 24646305 [TBL] [Abstract][Full Text] [Related]
18. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762. Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885 [TBL] [Abstract][Full Text] [Related]
19. Selective synergistic anticancer effects of cisplatin and oridonin against human p53-mutant esophageal squamous carcinoma cells. Yang H; Wang J; Khan S; Zhang Y; Zhu K; Zhou E; Gong M; Liu B; Kan Q; Zhang Q Anticancer Drugs; 2022 Jan; 33(1):e444-e452. PubMed ID: 34520434 [TBL] [Abstract][Full Text] [Related]